# Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee

> **NCT01768975** · PHASE2 · COMPLETED · sponsor: **Olatec Therapeutics LLC** · enrollment: 79 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **DRUG:** OLT1177 Gel
- **OTHER:** Placebo gel

## Key facts

- **NCT ID:** NCT01768975
- **Lead sponsor:** Olatec Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01768975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01768975, "Phase 2 Efficacy Trial of OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With OA of the Knee". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01768975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*